Post-IPO Debt - Coherus Biosciences
Investment Firm
Overview
Coherus Biosciences develops, manufactures, and commercializes biologic therapeutics for oncology and inflammatory diseases.
Announced Date
Jan 01, 2022
Funding Type
Post Ipo Debt
Highlights
Location
United States, North America
Social
Investor Lead
N/A
Participant Investors
1
| Investor Name |
|---|
 Armentum Partners |
Round Details and Background
Coherus Biosciences raised $400000000 on 2022-01-01 in Post-IPO Debt
Coherus Biosciences develops, manufactures, and commercializes biologic therapeutics for oncology and inflammatory diseases.
Company Funding History
16
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Mar 01, 2011 |  Series A - Coherus Biosciences | 2 | - | 1.5M |
| May 19, 2014 | Series C - Coherus Biosciences | 12 | - | 54.7M |
| Jul 25, 2013 | Debt Financing - Coherus Biosciences | 1 | - | 28.0M |
| Jan 01, 2012 | Series B - Coherus Biosciences | 5 | - | 61.5M |
Recent Activity
There is no recent news or activity for this profile.